FIGS logo

FIGS (FIGS) Company Overview

Profile

Full Name:

FIGS, Inc.

Country:

United States

IPO:

May 27, 2021

Indexes:

Not included

Description:

FIGS is a company that designs and sells stylish, comfortable scrubs and medical apparel for healthcare professionals. Founded in 2013, it focuses on high-quality materials and innovative designs, aiming to improve the work experience of doctors, nurses, and other medical staff.

Key Details

Price

$5.50

Annual Revenue

$545.65 M(+7.87% YoY)

Annual EPS

$0.12(+9.09% YoY)

Beta

1.09

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 10, 24 Goldman Sachs
Sell
Nov 13, 24 Telsey Advisory Group
Market Perform
Nov 12, 24 Barclays
Equal-Weight
Nov 4, 24 Telsey Advisory Group
Market Perform
Aug 9, 24 Telsey Advisory Group
Market Perform
Aug 9, 24 Goldman Sachs
Sell
Aug 5, 24 Telsey Advisory Group
Market Perform
Jun 13, 24 Telsey Advisory Group
Market Perform
May 10, 24 Telsey Advisory Group
Market Perform
May 10, 24 Roth MKM
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Scrubs maker Figs rebuffs Story3 Capital's take-private offer
Scrubs maker Figs rebuffs Story3 Capital's take-private offer
Scrubs maker Figs rebuffs Story3 Capital's take-private offer
FIGS
reuters.comJanuary 16, 2025

Figs said on Thursday it has rebuffed private equity firm Story3 Capital Partners' offer to acquire the scrubs maker.

Figs stock price sits in a range: will it have a breakout in 2025?
Figs stock price sits in a range: will it have a breakout in 2025?
Figs stock price sits in a range: will it have a breakout in 2025?
FIGS
invezz.comDecember 31, 2024

Figs stock has lost momentum and remained in a consolidation phase in almost two years. It remained inside the support and resistance levels at $4.42 and $6.97 in this period, missing the strong stock surge in the United States.

Applied Fundamental Research Issues Open Letter to FIGS Management and its Board of Directors
Applied Fundamental Research Issues Open Letter to FIGS Management and its Board of Directors
Applied Fundamental Research Issues Open Letter to FIGS Management and its Board of Directors
FIGS
businesswire.comDecember 20, 2024

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Applied Fundamental Research, a long-term shareholder of FIGS, Inc. (NYSE: FIGS), has submitted an open letter to the company's management and its Board of Directors. The letter highlights FIGS' exceptional achievements in transforming the healthcare apparel market, expresses confidence in the company's ability to execute its growth strategy as a public company, and outlines recommendations for defining a clear capital allocation strategy to unlock shareholder.

FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business
FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business
FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business
FIGS
seekingalpha.comDecember 16, 2024

An opportunistic offer by a PE fund during a 'retail lull' grossly undervalues FIGS, thus providing a chance for value and arbitrage investors to profit from the situation. Founded by Heather Hasson and Trina Spear, the stock has dropped from over $35 to $6.07 since its 2021 IPO and subsequent takeover offer. Story3 Capital's $6 per share offer to take the company private undervalues the business, which has strong free cash flow and no debt.

Is Figs a Buy After $1 Billion Buyout Rumors?
Is Figs a Buy After $1 Billion Buyout Rumors?
Is Figs a Buy After $1 Billion Buyout Rumors?
FIGS
fool.comDecember 13, 2024

Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.

Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm
FIGS
wsj.comDecember 10, 2024

The Story3 proposal values the company at more than $1 billion.

FIGS Back To Q1 Prices, But The Name Is Still A Hold
FIGS Back To Q1 Prices, But The Name Is Still A Hold
FIGS Back To Q1 Prices, But The Name Is Still A Hold
FIGS
seekingalpha.comNovember 13, 2024

Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest.

FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript
FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript
FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript
FIGS
seekingalpha.comNovember 9, 2024

FIGS, Inc. (NYSE:FIGS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Dana Telsey - Telsey Group Josh Reiss - Raymond James Bob Drbul - Guggenheim Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Nathan Feather - Morgan Stanley John Kernan - TD Cowen Ashley Owens - KeyBanc Capital Markets Operator Thank you for standing by, and good afternoon. Thank you for attending today's FIGS' Third Quarter Fiscal 2024 Earnings Conference Call.

FIGS, Inc.: Growth Potentially Inflecting Upwards
FIGS, Inc.: Growth Potentially Inflecting Upwards
FIGS, Inc.: Growth Potentially Inflecting Upwards
FIGS
seekingalpha.comOctober 3, 2024

I rate FIGS, Inc. stock as a buy, expecting growth to inflect upwards with orders per buyer potentially more than doubling. FIGS has enhanced top-of-funnel awareness, product innovation, and distribution capacity, driving customer acquisition beyond its core scrub customer base. Margin pressures are temporary; scaling non-scrub products and the high-margin TEAMS business should flip this headwind into a tailwind.

FIGS Q2 2024 Shows Growth At The Expense Of Margins. The Stock Is Still Overpriced
FIGS Q2 2024 Shows Growth At The Expense Of Margins. The Stock Is Still Overpriced
FIGS Q2 2024 Shows Growth At The Expense Of Margins. The Stock Is Still Overpriced
FIGS
seekingalpha.comSeptember 5, 2024

FIGS' Q2 2024 results showed moderate revenue growth but at the expense of lower margins due to increased spending on products and marketing. The company's lack of cost management and high gross margins make it vulnerable to competition, justifying my Hold rating. Despite some improvement in guidance, the valuation remains unattractive with the stock trading at a high P/E ratio even under optimistic scenarios.

FAQ

  • What is the ticker symbol for FIGS?
  • Does FIGS pay dividends?
  • What sector is FIGS in?
  • What industry is FIGS in?
  • What country is FIGS based in?
  • When did FIGS go public?
  • Is FIGS in the S&P 500?
  • Is FIGS in the NASDAQ 100?
  • Is FIGS in the Dow Jones?
  • When was FIGS's last earnings report?
  • When does FIGS report earnings?
  • Should I buy FIGS stock now?

What is the ticker symbol for FIGS?

The ticker symbol for FIGS is NYSE:FIGS

Does FIGS pay dividends?

No, FIGS does not pay dividends

What sector is FIGS in?

FIGS is in the Consumer Cyclical sector

What industry is FIGS in?

FIGS is in the Apparel Manufacturing industry

What country is FIGS based in?

FIGS is headquartered in United States

When did FIGS go public?

FIGS's initial public offering (IPO) was on May 27, 2021

Is FIGS in the S&P 500?

No, FIGS is not included in the S&P 500 index

Is FIGS in the NASDAQ 100?

No, FIGS is not included in the NASDAQ 100 index

Is FIGS in the Dow Jones?

No, FIGS is not included in the Dow Jones index

When was FIGS's last earnings report?

FIGS's most recent earnings report was on Nov 7, 2024

When does FIGS report earnings?

The next expected earnings date for FIGS is Feb 28, 2025

Should I buy FIGS stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions